Mostrando 10 resultados de: 14
Filtros aplicados
Subtipo de publicación
Article(14)
Publisher
American Journal of Tropical Medicine and Hygiene(4)
Transactions of the Royal Society of Tropical Medicine and Hygiene(2)
Acta Tropica(1)
BMC Infectious Diseases(1)
Frontiers in Physiology(1)
Área temáticas
Enfermedades(10)
Microorganismos, hongos y algas(5)
Fisiología humana(2)
Medicina forense; incidencia de enfermedades(2)
Bioquímica(1)
A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate
ArticleAbstract: Objectives: To determine the efficacy and the immunomodulatory function of Z-100 alone or combined wPalabras claves:IL-10, IL-4, L. amazonensisAutores:Hashiguchi Y., Jorge Diego Marco, Kato H., Korenaga M., Manuel H. Calvopina, Paola Andrea BarrosoFuentes:scopusClinical criteria for Mucosal Leishmaniasis diagnosis in rural South America: A systematic literature review
ArticleAbstract: Background Mucosal Leishmaniasis (ML), a neglected tropical disease caused by Leishmania parasites,Palabras claves:Autores:Bezemerid J.M., de Vries H.J.C., Leeflang M.M.G., Machado P.R.L., Manuel H. Calvopina, Meesters K., Naveda C.L., Schallig H.D.F.H.Fuentes:googlescopusComparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis
ArticleAbstract: The randomized, controlled study compared the therapeutic efficacy and safety of two paromomycin-conPalabras claves:Antimonial drugs, drug safety, ECUADOR, Glucantime, leishmaniasis, Methylbenzonium chloride, paromomycin, Treatment, ureaAutores:Mancheno M., Manuel H. Calvopina, Mary Margaret Weigel, Rodrigo X. Armijos, Rodriguez R.Fuentes:scopusComparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis
ArticleAbstract: A well-tolerated single-day treatment regimen is required for the community-based treatment of pulmoPalabras claves:ECUADOR, Efficacy, Paragonimiasis, Paragonimus spp., TRICLABENDAZOLEAutores:Guderian R.H., Manuel H. Calvopina, Paredes W., Philip John CooperFuentes:scopusCase report: Evidence of tungiasis in the amazon rain forest of Ecuador
ArticleAbstract: Tungiasis occurs in tropical and subtropical areas in Central and South America and sub-Saharan AfriPalabras claves:Autores:Bezemer J.M., Manuel H. CalvopinaFuentes:googlescopusEfficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis
ArticleAbstract: Activation of innate immunity using adjuvants that activate Toll-like receptor 4 pathways have greatPalabras claves:Adjuvants, leishmaniasis, ONO-4007, VaccineAutores:Hashiguchi Y., Jorge Diego Marco, Korenaga M., Manuel H. Calvopina, Nonaka S., Paola Andrea Barroso, Philip John CooperFuentes:scopusHematological Parameters, Lipid Profile, and Cardiovascular Risk Analysis Among Genotype-Controlled Indigenous Kiwcha Men and Women Living at Low and High Altitudes
ArticleAbstract: Introduction: Human adaptation to high altitude is due to characteristic adjustments at every physioPalabras claves:Adaptation, Cardiovascular Risk, hematological profile, High altitude, Hypoxia, lipid profileAutores:David Portilla, Duta D., Esteban Ortiz-Prado, Germán Burgos, Johanna Mosquera-Moscoso, Jorge Eduardo Vásconez, Juan S. Izquierdo-Condoy, Katherine Simbaña-Rivera, Manuel H. Calvopina, Ochoa I., Viscor G.Fuentes:googlescopusFatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador
ArticleAbstract: Background: Chagas disease is caused by the haemoflagellate protozoan Trypanosoma cruzi. Currently,Palabras claves:DTU, ECUADOR, Fatal acute Chagas disease, TcI, TRYPANOSOMA CRUZIAutores:Ángel Gustavo Guevara, Gabriela Mardones Segovia, Jaime Alfredo Costales, Manuel H. Calvopina, William T. Cevallos, Yosselin VicuñaFuentes:scopusIntralesional infiltration with meglumine antimoniate for the treatment of leishmaniasis recidiva cutis in Ecuador
ArticleAbstract: Meglumine Antimoniate (MA), administered intramuscularly for 21 continuous days is the recommended tPalabras claves:Autores:Edison Puebla, Jessica Flores, Manuel H. Calvopina, Padilla J., Richard Loor, William T. Cevallos, Yolanda ParedesFuentes:scopusItraconazole in the treatment of New World mucocutaneous leishmaniasis
ArticleAbstract: Background. A well-tolerated oral drug is required for the treatment of mucocutaneous leishmaniasisPalabras claves:Autores:Ángel Gustavo Guevara, Davidson R., Hashiguchi Y., Manuel H. Calvopina, Philip John Cooper, Rodrigo X. ArmijosFuentes:scopus